Quiet Submillimeter MR Imaging of the Lung Is Feasible with a PETRA Sequence at 1.5 T.

Radiology

From the Center for Cardiothoracic Research of Bordeaux, University of Bordeaux, Bordeaux, France (G.D., P.O.G., M.F., M.M., P.B., F.L.); Inserm, Center for Cardiothoracic Research of Bordeaux, U1045, F-3300, 146 rue Léo Saignat, 33076 Bordeaux, France (G.D., P.O.G., M.F., M.M., P.B., F.L.); Department of Thoracic and Cardiovascular Imaging, Department of Respiratory Disease, Department of Functional and Respiratory Examination, Centre Hospitalier Universitaire (CHU) de Bordeaux, Pessac, France (G.D., J.M., P.O.G., M.M., P.B., F.L.); Department for Imaging of the Woman and Child, Pediatric Pneumology Unit, CHU de Bordeaux, Bordeaux, France (M.F., J.F.C.); CHU de Bordeaux, CIC 0005, Bordeaux, France (M.F.); and Department of Magnetic Resonance, Siemens Healthcare, Erlangen, Germany (D.G.).

Published: July 2015

Purpose: To assess lung magnetic resonance (MR) imaging with a respiratory-gated pointwise encoding time reduction with radial acquisition (PETRA) sequence at 1.5 T and compare it with imaging with a standard volumetric interpolated breath-hold examination (VIBE) sequence, with extra focus on the visibility of bronchi and the signal intensity of lung parenchyma.

Materials And Methods: The study was approved by the local ethics committee, and all subjects gave written informed consent. Twelve healthy volunteers were imaged with PETRA and VIBE sequences. Image quality was evaluated by using visual scoring, numbering of visible bronchi, and quantitative measurement of the apparent contrast-to-noise ratio (CNR) and signal-to-noise ratio (SNR). For preliminary clinical assessment, three young patients with cystic fibrosis underwent both MR imaging and computed tomography (CT). Comparisons were made by using the Wilcoxon signed-rank test for means and the McNemar test for ratios. Agreement between CT and MR imaging disease scores was assessed by using the κ test.

Results: PETRA imaging was performed with a voxel size of 0.86 mm(3). Overall image quality was good, with little motion artifact. Bronchi were visible consistently up to the fourth generation and in some cases up to the sixth generation. Mean CNR and SNR with PETRA were 32.4% ± 7.6 (standard deviation) and 322.2% ± 37.9, respectively, higher than those with VIBE (P < .001). Good agreement was found between CT and PETRA cystic fibrosis scores (κ = 1.0).

Conclusion: PETRA enables silent, free-breathing, isotropic, and submillimeter imaging of the bronchi and lung parenchyma with high CNR and SNR and may be an alternative to CT for patients with cystic fibrosis.

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.15141655DOI Listing

Publication Analysis

Top Keywords

cystic fibrosis
12
submillimeter imaging
8
petra sequence
8
image quality
8
patients cystic
8
cnr snr
8
imaging
7
petra
7
quiet submillimeter
4
lung
4

Similar Publications

Perinatal dysfunction of innate immunity in cystic fibrosis.

Sci Transl Med

January 2025

First Department of Medicine, Cardiology, TUM University Hospital, Technical University of Munich, School of Medicine and Health, Munich 81675, Germany.

In patients with cystic fibrosis (CF), repeated cycles of infection and inflammation eventually lead to fatal lung damage. Although diminished mucus clearance can be restored by highly effective CFTR modulator therapy, inflammation and infection often persist. To elucidate the role of the innate immune system in CF etiology, we investigated a CF pig model and compared these results with those for preschool children with CF.

View Article and Find Full Text PDF

A new era of cystic fibrosis therapy with CFTR modulators.

J Bras Pneumol

January 2025

. Grupo de Pesquisa em Epidemiologia e Genética das Doenças Respiratórias da Infância, Pontifícia Universidade Católica do Rio Grande do Sul - PUCRS - Porto Alegre (RS) Brasil.

View Article and Find Full Text PDF

The complex (BCC) is a group of Gram-negative bacteria that cause opportunistic infections, most notably in people with cystic fibrosis (CF), and have been associated with outbreaks caused by contaminated medical products. Antimicrobial susceptibility testing (AST) is often used to guide treatment for BCC infections, perhaps most importantly in people with CF who are being considered for lung transplant. However, recent studies have highlighted problems with AST methods.

View Article and Find Full Text PDF

is an understudied, gram-negative, aerobic bacterium that is widespread in the environment and increasingly a cause of opportunistic infections. Treating remains difficult, leading to an increase in disease severity and higher hospitalization rates in people with cystic fibrosis, cancer, and other immunocompromised health conditions. The lack of effective antibiotics has led to renewed interest in phage therapy; however, there remains a great need for well-characterized phages, especially against .

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!